Fig. 4.

Effect of encapsulated glutamine upon concentrations of total GLP-1, insulin and glucose, and subjective measurements of hunger, fullness and nausea in subjects with type 2 diabetes before and after an oral glucose tolerance test (OGTT) which was given immediately after the 90 min sampling. Capsules were administered at time 0, immediately after baseline blood samples were taken. 8 participants attended on 2 occasions and took either placebo or 6.0 g Glutamine in a randomised, blinded, cross-over design. Data represent mean ± SEM.